Brief: Quince Therapeutics - Changes Name To Irulya Therapeutics
09/10/2026 13:12
BRIEF-Quince Therapeutics - Changes Name To Irulya Therapeutics Oct 9 (Reuters) - Quince Therapeutics, Inc. QNCX.O:
QUINCE THERAPEUTICS - CHANGES NAME TO IRULYA THERAPEUTICS
QUINCE THERAPEUTICS - COMMON STOCK TO TRADE UNDER SYMBOL 'IRLA' ON NASDAQ EFFECTIVE OCT 12, 2026
Source text: ID:nGNX9Gx1BL
Further company coverage: QNCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges